You are here

Article Text

Article menu
Download PDFPDF
Commentary
What have we learned after four randomized controlled trials on neoadjuvant chemotherapy for ovarian cancer?

https://doi.org/10.1136/ijgc-2020-002268

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    PDF extract preview

    You do not have access to the full text of this article, the first page of the PDF of this article appears above.

    Footnotes

    • Twitter @HsuMd

    • Contributors Both authors contributed equally to drafting and revising the manuscript and have approved the final version for publication.

    • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

    • Competing interests None declared.

    • Patient consent for publication Not required.